îãŠã©ãããªã¹ãã«è¿œå
ååŒæé 11/02, 15:16ïŒETïŒ
20.94MæäŸ¡ç·é¡
115.68çŽè¿12ã¶æPER
TXMD 財åæ
å ±
ã¹ããŒãæè³å®¶åãã«èšèšããããªãŒã«ã€ã³ã¯ã³ã®ããŒã¿ããã·ã¥ããŒãã§ãTherapeuticsMD Incã®è²¡åç¶æ³ã確èªã§ããŸãããã®ãã©ãããã©ãŒã ã¯ãè€éãªè²¡åè«žè¡šãæŽçããŠã«ã¹ã¿ãã€ãºå¯èœãªãã¥ãŒã«ãã詳现ãªè²¡ååæãæäŸããŸããææ°ã®å¹ŽåºŠè²¡åå ±åæžã«ã¢ã¯ã»ã¹ããããæçèšç®æžã貞å察ç
§è¡šããã£ãã·ã¥ãããŒèšç®æžã䜿ã£ãŠååæããšã®ããã©ãŒãã³ã¹ãåæããããšãã§ããŸãããªã¢ã«ã¿ã€ã ã®è²¡åææšãæå
ã«çœ®ããŠãäŒæ¥ã®åžå Žå¥åº·ç¶æ
ãç¶ç¶çã«ç£èŠããããšããããŸã§ä»¥äžã«ç°¡åã«ãªããŸããã
éèŠãªè²¡åæ¯ç
1æ ªåœããå©çïŒEPSïŒ
0.02
èªå·±è³æ¬å©çç
0.32%
財å諞衚ã®ãã€ã©ã€ã
ãããã質å
TherapeuticsMD Incã®å£²äžé«ã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšã売äžé«ã¯3.02Mã§ãåå¹Žåææ¯1.76Mã§ããã
TherapeuticsMD Incã®æµåè³ç£ã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãæµåè³ç£ã¯14.45Mã§ãå幎æ¯17.83ã®å€åããããŸããã
TherapeuticsMD Incã®ç·è³ç£ã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç·è³ç£ã¯37.66Mã§ãåå¹Žåææ¯-3.00ã§ããã
TherapeuticsMD Incã®ç·è² åµã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç·è² åµã¯10.78Mã§ãåå¹Žåææ¯-5.87ã§ããã
TherapeuticsMD Incã®èªå·±è³æ¬ã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãèªå·±è³æ¬ã¯26.88Mã§ãåå¹Žåææ¯-1.80ã§ããã
TherapeuticsMD Incã®å¶æ¥å©çã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãå¶æ¥å©çïŒNet Operating IncomeïŒã¯-4.21Mã§ãåå¹Žåææ¯13.01ã§ããã
TherapeuticsMD Incã®1æ ªåœããå©çïŒEPSïŒã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšã1æ ªåœããå©çïŒEPSïŒã¯-0.05ã§ãå幎æ¯74.00ã®å€åããããŸããã
TherapeuticsMD Incã®çŽå©çã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãçŽå©çã¯-569.00Kã§ãå幎æ¯73.91ã®å€åããããŸããã
TherapeuticsMD Incã®çŽå©ççã¯ã©ã®ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãçŽå©ççã¯-21.61ã§ãå幎æ¯83.54ã®å€åããããŸããã
TherapeuticsMD Incã®æ ªäž»è³æ¬å©ççïŒROEïŒã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãæ ªäž»è³æ¬å©ççïŒROEïŒã¯-2.41ã§ãå幎æ¯70.50ã®å€åããããŸããã
TherapeuticsMD Incã®ç·è³ç£å©ççïŒROAïŒã¯ãããã§ããïŒ
îTherapeuticsMD Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç·è³ç£å©ççïŒROAïŒã¯-1.71ã§ãå幎æ¯69.67ã®å€åããããŸããã